| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,215 |
1,977 |
$152K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
632 |
632 |
$66K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
487 |
469 |
$50K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
438 |
436 |
$37K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,795 |
1,786 |
$9K |
| 99177 |
|
1,062 |
1,061 |
$7K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
61 |
61 |
$5K |
| 90686 |
|
647 |
643 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
907 |
907 |
$2K |
| 99051 |
|
107 |
107 |
$638.78 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
117 |
75 |
$517.02 |
| 90698 |
|
142 |
142 |
$275.86 |
| 90685 |
|
94 |
94 |
$223.82 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
129 |
124 |
$201.26 |
| 90670 |
|
351 |
351 |
$187.32 |
| 96127 |
|
75 |
75 |
$157.36 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
12 |
$157.01 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
104 |
102 |
$84.49 |
| 90633 |
|
27 |
27 |
$0.00 |
| 90474 |
|
77 |
77 |
$0.00 |
| 90680 |
|
77 |
77 |
$0.00 |
| 90651 |
|
14 |
14 |
$0.00 |